Page 26 - FLIPBOOK
P. 26
Degarelix significantly reduces the risk of subsequent CV events in
patients with preexisting history of cardiovascular disease.
Probability of a severe CV event or death Probability of a severe CV event or death
HR=0.44; 95% CI 0.26–0.74; p=0.002
CVD history was defined as an event of myocardial ischaemia, coronary artery disease, myocardial infarction,
cerebrovascular accident, angina pectoris or coronary artery bypass at baseline
Albertsen PC, et al. Eur Urol 2014;65:565–73
